Apyx Medical Corporation (APYX) vs Hyperfine, Inc. (HYPR)
Apyx Medical Corporation and Hyperfine, Inc. are both Medical Devices companies. Apyx Medical Corporation is the larger, with a market value of $119.2M against $84.4M — 1.4× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 25.6%. Apyx Medical Corporation has the higher net margin (−14.8% vs −210.8%) and the higher return on invested capital (−11.8% vs −401.8%). Across the 18 metrics below, Apyx Medical Corporation leads on 13 and Hyperfine, Inc. on 5.
Valuation
Profitability
| Metric | APYX | HYPR | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.50% | 51.41% | 56.01% |
| Operating margin | (6.06%) | (203.27%) | (15.03%) |
| Net margin | (14.78%) | (210.75%) | (20.40%) |
| Free cash flow margin | (18.91%) | (166.48%) | (7.24%) |
| Return on equity | (93.11%) | (96.97%) | (15.32%) |
| Return on assets | (14.48%) | (64.40%) | (19.72%) |
| Return on invested capital | (11.76%) | (401.79%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack